Dismantling of the Components of the Nuclear Pore Comlex during Apoptosis
Monika Patre(Roche (Switzerland))
KOPS (University of Konstanz)
January 1, 2004
Cited by 0
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Untersuchungen am Kernporen-Komplex während der Apoptose
|KOPS (University of Konstanz)|2004|0